Akums Drugs and Pharmaceuticals Inkomsten in het verleden
Verleden criteriumcontroles 4/6
Akums Drugs and Pharmaceuticals has been growing earnings at an average annual rate of 15.8%, while the Life Sciences industry saw earnings growing at 20.2% annually. Revenues have been growing at an average rate of 13.9% per year. Akums Drugs and Pharmaceuticals's return on equity is 34.6%, and it has net margins of 5.8%.
Belangrijke informatie
15.8%
Groei van de winst
15.8%
Groei van de winst per aandeel
| Life Sciences Groei van de industrie | 11.2% |
| Inkomstengroei | 13.9% |
| Rendement op eigen vermogen | 34.6% |
| Nettomarge | 5.8% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Akums Drugs and Pharmaceuticals geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 42,309 | 2,444 | 7,115 | 0 |
| 31 Mar 24 | 41,817 | -40 | 6,918 | 0 |
| 31 Dec 23 | 40,846 | -671 | 6,737 | 0 |
| 30 Sep 23 | 39,875 | -1,302 | 6,555 | 0 |
| 30 Jun 23 | 37,158 | -1,277 | 6,258 | 0 |
| 31 Mar 23 | 36,572 | 949 | 6,291 | 0 |
| 31 Mar 22 | 36,752 | -2,525 | 5,399 | 0 |
| 31 Mar 21 | 27,262 | 1,227 | 4,541 | 0 |
Kwaliteitswinsten: AKUMS has high quality earnings.
Groeiende winstmarge: AKUMS became profitable in the past.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: AKUMS has become profitable over the past 5 years, growing earnings by 15.8% per year.
Versnelling van de groei: AKUMS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Winst versus industrie: AKUMS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Life Sciences industry (13.3%).
Rendement op eigen vermogen
Hoge ROE: AKUMS's Return on Equity (34.6%) is considered high.